NVSEF News and Press, Novartis Ag Basel Akt From 06/25/21

The following slide deck was published by Novartis AG in conjunction with this event. For further details see: Novartis (NVS) Iptacopan (LNP023) Update - Slideshow

The Vanguard International High Dividend Yield ETF is a decent investment, but it is not a vehicle to achieve "high yield". According to my math, the LTM distributions equate to a 2.88% yield. But before you turn away, VYMI's one-year total returns are an impressive 45.5% (yes, as...

AstraZeneca's innovative culture earned it a place as one of the leading biotechs globally. Revenue growth from COVID vaccine sales and some key markets provide strong tailwinds for the company's share in the second half of 2021. Most of AstraZeneca's revenue comes from a handful ...

This technology-focused healthcare infrastructure platform connects payors, providers, and employers in an efficient and analytical way. As a new growth-based company seeing 40% CAGR revenues over the past two years, net income remains negative but profitability is higher than their p...

Novartis AG (NVS) Cardiovascular Update Call May 18, 2021, 11:30 ET Company Participants Samir Shah - Global Head, IR David Soergel - Head, Cardiovascular, Renal & Metabolic Development Group Rod Wooten - Global Head, Marketing of Novartis Pharmaceuticals Victor Bulto - Head, US Pharmaceu...

Kahn Brothers’ 13F portfolio value increased from $579M to $646M this quarter. Stakes in VOXX International and BlackBerry were decreased during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~45% of the 13F holdings....

Healthcare offers essential services that people can't go without, recession or not. The Tekla funds can offer potential in any one of their funds for healthcare exposure. Today we explore the differences and the similarities of the funds. For further details see: Tekla ...

ARKG’s Sharpe Ratio and outperformance suggest great stock-picking by the fund manager. However, the neutral rating is premised on a long-term time horizon for value realization in view of ARKG’s rich valuation. Furthermore, the general market is not unequivocally ri...

Fisher’s 13F portfolio value increased from ~$133.5B to ~$142B in Q1 2021. They increased Walt Disney and Eli Lilly while trimming Taiwan Semi, JD.com, and Pinduoduo. Fisher has a number of small positions in several ETFs/ETNs. For further details see: Tracking Ke...

Novartis AG (NVS) Q1 2021 Earnings Conference Call April 27, 2021 8:00 AM ET Company Participants Samir Shah – Global Head-Investor Relations Vas Narasimhan – Chief Executive Officer Marie-France Tschudin – President-Novartis Pharmaceuticals Richard Saynor – Chief ...